Advertisement
If you have a new account but are having problems posting or verifying your account, please email us on hello@boards.ie for help. Thanks :)
Hello all! Please ensure that you are posting a new thread or question in the appropriate forum. The Feedback forum is overwhelmed with questions that are having to be moved elsewhere. If you need help to verify your account contact hello@boards.ie

Vaccine Megathread No 2 - Read OP before posting

Options
1267268270272273299

Comments

  • Registered Users Posts: 102 ✭✭tfeldi


    I see that other countries are publishing incidence rates for vaccinated vs. unvaccinated. Example Austria: They have introduced a lockdown for the unvaccinated. The reason given is that the incidence rate for the unvaccinated is 1700 vs. less than 400 (and slightly falling) for vaccinated for the age group of 18 - 59 year olds. Irrespective of the question if a lockdown for the unvaccinated makes sense or not, I think these numbers are quite powerful. Why is this not being tracked / published here?



  • Registered Users Posts: 8,501 ✭✭✭Red Silurian


    Austria have also introduced vaccines for 5-11 year olds... Fair play to them, somebody had to stick the middle finger to the EMA's ridiculously slow approval process



  • Registered Users Posts: 31,025 ✭✭✭✭Lumen


    That's an extremely weird decision, given that they have one of the lowest adult take-ups in Europe.



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    This will almost certainly come back to haunt them and is a ridiculous decision.

    Safety data for 5-11 year olds was published literally only 5 days ago and is not promising. E.g. from Pfizer: Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM

    "Adverse events from the first dose through 1 month after the second dose were reported by 43.8% of participants who received two 10-μg doses of BNT162b2"

    ...

    "Frequencies of fatigue, headache, and chills were similar among BNT162b2 and placebo recipients after the first dose and were more frequent among BNT162b2 recipients than among placebo recipients after the second dose. In general, systemic events were reported more often after the second dose of BNT162b2 than after the first dose. Fever occurred in 8.3% of BNT162b2 recipients after the first or second dose. Use of an antipyretic among BNT162b2 recipients was more frequent after the second dose than after the first dose. One BNT162b2 recipient had a temperature of 40.0°C (104°F) 2 days after the second dose; antipyretics were used, and the fever resolved the next day."

    ...

    "This study was also not powered to detect potential rare side effects of BNT162b2 in 5-to-11-year-olds. However, the safety of BNT162b2 observed in the study combined with widespread use of BNT162b2 in older populations should provide reassurance."



  • Registered Users Posts: 28,396 ✭✭✭✭odyssey06


    "However, the safety of BNT162b2 observed in the study combined with widespread use of BNT162b2 in older populations should provide reassurance."

    Nothing there suggesting unsafe for kids, just a temporary feeling of being unwell which paracetamol helps with and then resolves... your headline is fake news compared to the details.

    "To follow knowledge like a sinking star..." (Tennyson's Ulysses)



  • Advertisement
  • Registered Users Posts: 32,136 ✭✭✭✭is_that_so


    It looks like an attempt to get a higher overall vaccination rate but seems to presume that parents will consent do so. We know from our 12-15 year olds that may not happen.



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    "However, the safety of BNT162b2 observed in the study combined with widespread use of BNT162b2 in older populations should provide reassurance."

    You realise I posted that quote yes? Do you understand the context of the quote, which I also posted?

    The safety study they undertake is NOT sufficiently powered to detect rare side effects. Their "reassurance" is based on studies with other populations, and is NOT a finding from this safety trial. I posted this quote because it's a very bad attribute of this trial.

    By the way, a 2 day fever of 40 degrees is no joke, and is classed as a serious adverse outcome in the study.

    Like I said, this decision will almost certainly come back to haunt them.



  • Registered Users Posts: 28,396 ✭✭✭✭odyssey06


    The quote states "The safety of BNT162b2 observed in the study"

    This is the conclusion of the report you linked to:

    A Covid-19 vaccination regimen consisting of two 10-μg doses of BNT162b2 administered 21 days apart was found to be safe, immunogenic, and efficacious in children 5 to 11 years of age... The data reported herein support vaccination of 5-to-11-year-old children with two 10-μg doses of the BNT162b2 vaccine.

    It's the report you picked, and that's what it states. Important to call that out because it contradicts the spin you wrapped around it.

    "To follow knowledge like a sinking star..." (Tennyson's Ulysses)



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    the spin you wrapped around it.

    What you're doing here is ignoring the actual content of the trial, and instead posting lines from the conclusion. That is spin.

    I posted their safety findings and I've read the report and data supplements in detail. Do you believe that a serious adverse outcome in 1% of participants, in a study not designed to catch such signals, for a population who are almost entirely unaffected by covid, is safe?

    Is your belief that it's safe entirely based on a line in a conclusion that says "it's found to be safe"?

    It's the report you picked

    This is the safety/efficacy trial publication from Pfizer, not just an arbitrary report that I chose.



  • Registered Users Posts: 28,396 ✭✭✭✭odyssey06


    Where in the report does it state it was not designed to detect serious adverse outcomes.

    "In the 5-to-11-year-olds, as in other age groups, the BNT162b2 vaccine had a favorable safety profile. No vaccine-related serious adverse events were noted."

    Within the limits of the trial conducted the vaccine was found to be safe, or to put it another way, within the limits of the trial conducted no safety issues were detected. So no, I don't know if it's safe, but I see nothing in this to indicate it is unsafe.

    The spin you are putting on the report is your own, and should be declared as such and is not supported by the report and is in fact contradicted by its conclusion.

    "To follow knowledge like a sinking star..." (Tennyson's Ulysses)



  • Advertisement
  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Where in the report does it state it was not designed to detect serious adverse outcomes.

    "This study was also not powered to detect potential rare side effects of BNT162b2 in 5-to-11-year-olds."

    To my reading, the protocol (in the supplements) lists the "rare side effects" as myocarditis, pericarditis, and anaphylaxis. In the adult trial these were catagorised under serious adverse outcomes rather than "rare side effects".

    The spin you are putting on the report is your own, and should be declared as such and is not supported by the report and is in fact contradicted by its conclusion.

    I've pasted a paragraph from the safety section verbatim. If you believe that something is safe enough, when we're told 1% of the child population had a serious adverse outcome, entirely because a conclusion says "it's safe", then that's up to you.



  • Registered Users Posts: 28,396 ✭✭✭✭odyssey06



    Where is your source for 1% of the child population having a serious adverse outcome?

    And nowhere in the report does it state it was not designed to detect serious adverse outcomes. That was your claim, and it is untrue. It did look for serious adverse outcomes within the parameters of the trial and it did look for adverse events such as myocarditis. Because of its parameters it was not designed to detect rare events - whether serious or not. If myocarditis was rare its' size may mean it would not detect it, but it was looking for serious adverse events.

    Severe adverse events were reported in 0.1% of BNT162b2 recipients and 0.1% of placebo recipients. Three serious adverse events in two participants were reported by the cutoff date; all three (postinjury abdominal pain and pancreatitis in a placebo recipient and arm fracture in a BNT162b2 recipient) were considered to be unrelated to the vaccine or placebo. No deaths or adverse events leading to withdrawal were reported... No vaccine-related serious adverse events were noted.

    Data on unsolicited adverse events, including confirmed diagnoses of myocarditis or pericarditis, were collected from the first dose through 1 month after the second dose... Neither myocarditis nor pericarditis was observed.

    "To follow knowledge like a sinking star..." (Tennyson's Ulysses)



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Where is your source for 1% of the child population having a serious adverse outcome?

    My fault, I was off by a power of 10, I meant 0.1%. Regardless, the risk of ICU for children in this cohort is approximately 1 in a million, and the risk of severe outcomes from this trial is 1 in 1000. That's not good.

    It did look for serious adverse outcomes within the parameters of the trial and it did look for adverse events such as myocarditis. Because of its parameters it was not designed to detect rare events - whether serious or not. If myocarditis was rare its' size may mean it would not detect it, but it was looking for serious adverse events.

    Of course it's looking for serious adverse outcomes, however they tell you it isn't sufficiently powered to detect rare side effects including myocarditis.

    No vaccine-related serious adverse events were noted.

    This sentence in the intro doesn't make sense because they do report a vaccine-related serious adverse outcome, phase 2-3 safety:


    And the protocol, which classes such a fever as a serious adverse outcome:




  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Oh wait I see. A fever is classed as a severe outcome if it's >40, not >=40. That child only had a fever of 40.00, so it's not severe.



  • Registered Users Posts: 28,396 ✭✭✭✭odyssey06


    0.1% was also the same outcome observed in the placebo group.

    Severe adverse events were reported in 0.1% of BNT162b2 recipients and 0.1% of placebo recipients.

    The fever was not a serious adverse event (as per Appendix 3 of the Protocol), and did not meet the stopping rule criteria for duration as it resolved itself within 24 hours when treated with antipyretics  (e.g. paracetamol).

    So your claims about the report have shown to be untrue e.g. that the study was not design to catch serious adverse events or that 1% of children getting the vaccine in the trial experienced serious adverse outcomes. I think it's pretty clear and obvious any claims made by you about this report cannot be trusted and are likely to be untrue.

    Within the parameters of the trial, it has not found any safety issues with the vaccine dose for children of this age group, completely contrary to the 'spin' you attempt to surround it with.

    No vaccine-related serious adverse events were noted.

    "To follow knowledge like a sinking star..." (Tennyson's Ulysses)



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    The fever was not a serious adverse event (as per Appendix 3 of the Protocol), and did not meet the stopping rule criteria for duration as it resolved itself within 24 hours when treated with antipyretics (e.g. paracetamol).

    The stopping rule duration isn't resolution within 24 hours after treatment, it's that they have a >40.0 fever for >=1 day after vaccination, and to my reading that child had a fever that was resolved 3 days after their second dose, albeit it was 40.0. If it was 40.01 it'd be classed as serious.

    So your claims about the report have shown to be untrue e.g. that the study was not design to catch serious adverse events 

    It wasn't sufficiently powered to catch signals from rare side effects. What rare side effects does it mean?



  • Registered Users Posts: 2,233 ✭✭✭ceegee


    The rare side effects it means are those that generally occur at rates lower than the size of the study.

    Ie if you study 1000 children, and don't detect any occurrences of a side effect that generally occurs in 1 in a million people, you can't determine if the absence of that side effect is due to (a) it not happening to children, or (b) coincidence due to the size of the group relative to likelihood of side effect.



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Ah I get that but I mean what ones specifically. E.g. the adult trial talks about Bell's Palsy. The sample size in this trial is tiny so it'd be useful to know what side effects or outcomes it is unable to detect in comparison to the adult trial.



  • Registered Users Posts: 1 Cmor123


    Hi all. Would I be correct in saying that someone who has received Covaxin (a COVID-19 vaccine developed and produced in India and recently approved by the WHO) should be considered fully vaccinated in Ireland?

    Reference: HSE Clinical Guidance for COVID‐19 Vaccination - Section 15.20: "those who have documentary evidence of a complete COVID-19 vaccination course with a COVID-19 vaccine authorised by the FDA, MHRA or recommended by WHO should be considered fully vaccinated"

    Asking for Indian family members. Thanks in advance (apologies I am unable to share link to HSE Document, but it can be found online)



  • Registered Users Posts: 3,778 ✭✭✭Apogee




  • Advertisement
  • Posts: 0 [Deleted User]




  • Registered Users Posts: 5,535 ✭✭✭Charles Babbage


    Almost entirely unaffected by Covid could easily still mean several % of the population. In these times, every child will get Covid, few will have problems with it, but few have problems with the vaccine either.



  • Posts: 0 [Deleted User]


    You have been thoroughly outed as a joke by @odyssey06 at this stage, purposely selecting what you think might suit your agenda while ignoring what you don’t like. Purporting to read the full study yet here you a claiming “study not designed to detect serious events still did”, yet completely missed this while bigging up a child who had a fever that resolved with paracetamol in a day

    Three serious adverse events in two participants were reported by the cutoff date; all three (postinjury abdominal pain and pancreatitis in a placebo recipient and arm fracture in a BNT162b2 recipient) were considered to be unrelated to the vaccine or placebo.


    The reason the sample was enough was that it established the pattern of side effects observed in children was similar but less frequent to that observed in adults, except at a lower level of systemic events with the exception of swollen glands. This was a confirmatory study to see could conclusions made for adults still hold in children. And it did, because children are humans too.

    As compared with adults and adolescents in the pivotal trial, 5-to-11-year-olds reported a higher incidence of injection-site redness (15 to 19%, vs. 5 to 7%) and swelling (10 to 15%, vs. 5 to 8%), but a generally lower incidence of systemic events, including fever (3 to 7%, vs. 1 to 20%) and chills (5 to 10%, vs. 6 to 42%).3,4 Lymphadenopathy was reported in 0.9% of 5-to-11-year-old BNT162b2 recipients, an incidence similar to that in 12-to-15-year-olds (0.8%) but higher than that observed in adults (0.3%)




  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Very possible. I'm not opposed to vaccinating anyone to reduce harm. My issue above is that Austria have approved it, a few days after a paper is published on a trial conducted on 1500 kids, which the manufacturer says is unable to detect rare side effects.



  • Registered Users Posts: 1,476 ✭✭✭floorpie


    Read the conversation and paper properly. The 3 serious adverse events you mention are unrelated to the cases of fever.

    The reason the sample was enough

    The sample wasn't enough to detect rare side effects that were detected in the more substantial adult trials.



  • Registered Users Posts: 1,570 ✭✭✭Tyrone212


    Irish times reporting that those who got J&J will be offered a booster. If they refuse will their covid pass be revoked I wonder?



  • Registered Users Posts: 14,235 ✭✭✭✭Cienciano


    Hard to see the point in it unless the child has underlying conditions. I don't think I'd bother, but my kids are 8 or 9



  • Registered Users Posts: 2,157 ✭✭✭Markus Antonius


    Funny how most reasonable people respect those who choose not to have their children vaccinated (including myself). But if I choose not to get vaccinated, I'm "antivaxr" scum who's higher viral load is killing everyone's granny



  • Registered Users Posts: 16,479 ✭✭✭✭astrofool


    We'll hit about 50% uptake I reckon, I'd be surprised if it was much lower or higher than that.



  • Advertisement
  • Registered Users Posts: 32,136 ✭✭✭✭is_that_so


    I'd see this as a likely approach in many households with small kids. Any who've not bothered with 12-15 will not do smaller ones.



Advertisement